Anti-Ulcer Effect of Ornithogalum umbellatum at Various Potencies in Indomethacin-Induced Gastric Ulceration in Sprague-Dawley Rats: A Pre-clinical Study Puja Bhakta, Manoharan Raja, Somasundaram Arumugam, Manoj Limbraj Yellurkar, Vani Sai Prasanna, et al. Homeopathy, 2026 Gastric ulceration is a major global health issue, and conventional anti-ulcer drugs often cause adverse effects, necessitating safer alternatives. Ornithogalum umbellatum (OrUm), traditionally referenced in homeopathy for gastrointestinal complaints, lacks thorough pre-clinical evaluation. This study investigated the anti-ulcer effects of OrUm in mother tincture (MT), 6C and 30C potencies using an indomethacin-induced gastric ulcer model in Sprague-Dawley rats. Thirty-six rats were divided into six groups (n = 6 per group). Five groups received indomethacin (30 mg/kg, subcutaneously) to induce ulcers. Four of these were treated orally for 7 days with esomeprazole (20 mg/kg), OrUm-MT, OrUm-6C, or OrUm-30C. One group served as disease control and another as normal control. Biochemical parameters (including SGOT, SGPT, ALP, urea, creatinine, glucose, protein), antioxidant markers (MDA, SOD) and histopathological changes were assessed. Liquid chromatography–mass spectrometry (LC–MS) was performed to analyze the phytochemical composition of OrUm-MT. OrUm-6C significantly improved SGOT, SGPT, ALP, urea, glucose, protein and MDA levels (p < 0.05), with histological evidence of mucosal healing. OrUm-MT significantly reduced SGPT and creatinine levels but showed mild ulceration histologically. OrUm-30C showed no significant biochemical improvement. LC-MS analysis of OrUm-MT revealed phenolic acids and flavonoids, which may underlie its antioxidant effects. This is the first pre-clinical study to demonstrate the anti-ulcer potential of OrUm. Among the tested potencies, OrUm-6C showed the most consistent biochemical and histopathological improvements. These findings support further investigation through rigorous pre-clinical and clinical studies to establish its therapeutic potential.
Liquid–Liquid Phase Separation: Mechanisms, Roles, and Implications in Cellular Function and Disease Dikesh Kumar Thakur, Sonal Padole, Tapati Sarkar, Somasundaram Arumugam, Shiladitya Chattopadhyay FASEB Bioadvances, 2025 Liquid–liquid phase separation is a basic biophysical process that creates essential membraneless organelles that support different cellular activities, including chromatin organization and gene expression. The malfunction of liquid–liquid phase separation (LLPS) plays a critical role in numerous diseases, such as neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD), which involve TDP‐43 and Tau, various cancers that utilize SPOP and YAP/TAZ proteins, and viral infections where pathogens use LLPS to replicate and avoid immune detection. This review brings together the fast‐growing knowledge about LLPS across multiple scientific fields. The paper examines the physiological functions of LLPS along with its disease pathogenesis mechanisms and presents various experimental techniques (e.g., advanced microscopy, FRAP, FCS) for its investigation. It introduces new therapeutic approaches such as PTM modulation, small molecules like 1,6‐hexanediol and Lipoamide, and advanced genetic tools including CRISPR and PROTACs like PSETAC, which also explores diagnostic applications. The thorough integration of knowledge presented here is essential to connect separate scientific findings while propelling research forward and turning LLPS discoveries into new biomedical developments.
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications International Journal of Pharmaceutical Compounding, 2023
Japanese Kampo Medicines for the Treatment of Common Diseases: Focus on Inflammation Japanese Kampo Medicines for the Treatment of Common Diseases Focus on Inflammation, 2017
General Mechanisms of Immunity and Inflammation Remya Sreedhar, Kenichi Watanabe, Somasundaram Arumugam Japanese Kampo Medicines for the Treatment of Common Diseases Focus on Inflammation, 2017
Introduction to Japanese Kampo Medicines Remya Sreedhar, Kenichi Watanabe, Somasundaram Arumugam Japanese Kampo Medicines for the Treatment of Common Diseases Focus on Inflammation, 2017
Japanese Kampo Medicine for Hepatic Inflammation Remya Sreedhar, Geetha Kandasamy, Shanish Antony, Somasundaram Arumugam Japanese Kampo Medicines for the Treatment of Common Diseases Focus on Inflammation, 2017
Mast cells in inflammatory bowel disease: Potential therapeutic targets for intestinal inflammation and fibrosis Mast Cells Phenotypic Features Biological Functions and Role in Immunity, 2013
Vimentin-positive, profibrogenic mesenchymal cells in intestine: Promising therapeutic targets for intestinal fibrosis Vimentin Concepts and Molecular Mechanisms, 2013
Diabetic Cardiomyopathy and Oxidative Stress Somasundaram Arumugam, Vengadeshprabhu Karuppagounder, Rajarajan A. Thandavarayan, Vigneshwaran Pitchaimani, Hirohito Sone, et al. Diabetes Oxidative Stress and Dietary Antioxidants, 2013
Development and validation of HPTLC method for estimation of quetiapine in bulk drug and in tablet dosage form International Journal of Pharmtech Research, 2009
Cassia roxburghii seeds protect liver against toxic effects of ethanol and carbontetrachloride in rats International Journal of Pharmtech Research, 2009
Simultaneous spectrophotometry estimation of nebivolol hydrochloride and hydrochlorothiazide in tablets Asian Journal of Chemistry, 2008
Optimized Chitosan–Lecithin Nanocarriers for Nose-to-Brain Delivery of Dalfampridine in Multiple Sclerosis: Box–Behnken Design Optimization, and Toxicity Evaluation J Therassama, JOJ Edward, S Arumugam, P Pazhani, JP Dharmian Journal of Pharmaceutical Innovation 21 (4), 415 , 2026 2026
Nanotechnology-driven therapeutic strategies for lambert–eaton myasthenic syndrome: Emerging drug delivery and immunomodulatory approaches J Therassama, JOJ Edward, S Arumugam, P Pazhani, JP Dharmian Next Nanotechnology 9, 100515 , 2026 2026
Protective Effects of Sitagliptin on Dextran Sulfate Sodium-Induced Colitis via Modulation of Inflammatory and Oxidative Stress V Soetikno, M Subangkit, AY Ramadhan, S Arumugam, R Sreedhar Medicina 62 (6), 1005 , 2026 2026
Reconstructing the complex architecture of the genome with molecular scissors: applying genome editing technology in precision medicine MNA Khan, R Das, P Barik, S Arumugam, S Chattopadhyay Frontiers in Genome Editing 8, 1762449 , 2026 2026
Anti-Ulcer Effect of Ornithogalum umbellatum at Various Potencies in Indomethacin-Induced Gastric Ulceration in Sprague-Dawley Rats: A Pre-clinical Study P Bhakta, M Raja, S Arumugam, ML Yellurkar, VS Prasanna, K Bhar, ... Homeopathy , 2026 2026
Atopic dermatitis: a mini review on pathology and treatment modalities A Sahu, R Sreedhar, S Arumugam Exploration of Asthma & Allergy 4, 1009105 , 2026 2026
New Insights Into the Metabolic Syndrome–Cancer Nexus T Bhattacharya, SS Bartwal, I Bhattacharya, M Dhanasekaran, ... Pharmacotherapy Approaches Toward Endocrine and Metabolic Diseases, 165-186 , 2026 2026
Zanubrutinib in liquid cancers a new horizon A Sahu, R Das, B Nath, T Bhattacharya, I Bhattacharya, S Arumugam Drug Discovery Stories, Volume 2, 553-563 , 2026 2026
Efficiency of phytochemicals to cure metabolic diseases by targeting mitophagy T Bhattacharya, I Bhattacharya, DK Dhaked, R Sreedhar, S Arumugam Plant-Based Drug Discovery, 209-218 , 2026 2026
Chitosan coated yeast microcapsules for efficient delivery of cefadroxil for the treatment of inflammatory bowel disease AISG Mohammed, V Hmingthansanga, P Das, S Arumugam, B Rajdev, ... International Journal of Biological Macromolecules, 149162 , 2025 2025 Citations: 2
Ellagic acid-imbedded MoO3 nanowires architecture: External mediator-less electrochemical immunoprobing of inflammatory bowel disease marker GR Pandey, S Arumugam, J Thulukanam, LK Vajravelu, M Veerapandian Biosensors and Bioelectronics 287, 117719 , 2025 2025 Citations: 2
A network pharmacology, molecular docking and in vitro investigation of Picrorhiza kurroa extract for the treatment of diabetic nephropathy S Pal, ML Yellurkar, P Das, V Sai Prasanna, S Sarkar, RL Gajbhiye, ... Journal of Biomolecular Structure and Dynamics 43 (15), 8385-8396 , 2025 2025 Citations: 5
Insights into decellularized matrix-based therapeutic delivery systems in myocardial infarction T Bhattacharya, M Kundu, P Patil, I Bhattacharya, NP Sibi, A Sahu, ... Journal of Drug Delivery Science and Technology, 107618 , 2025 2025
6-Gingerol protects against hypertrophic cardiomyopathy in high-fat diet/low-dose streptozotocin-induced diabetic rats A Yusuf Ramadhan, S Wijaya, D Saisa, S Nurfitriyanti, B Santoso, ... Research Journal of Pharmacognosy 12 (4), 35-46 , 2025 2025
Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement I Bhattacharya, DK Maity, A Kumar, S Sarkar, T Bhattacharya, A Sahu, ... Naunyn-Schmiedeberg's Archives of Pharmacology 398 (10), 13647-13665 , 2025 2025 Citations: 6
Comparative analysis of the oral and injectable form of heat-inactivated Salmonella Enteritidis vaccine efficacy in commercial chickens P Barik, S Ahmed, P Biswas, S Mondal, A Sahu, S Nath, U Mohan, S Babu, ... The Microbe, 100549 , 2025 2025
Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress L Nama, R Bhushan, P Kumar, S Arumugam, OP Ranjan, P Kumar, ... Journal of molecular histology 56 (4), 200 , 2025 2025 Citations: 4
Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism (vol 326, 117935, 2024) ML Yellurkar, VS Prasanna, P Das, S Sarkar, R Matta, DK Dhaked, ... JOURNAL OF ETHNOPHARMACOLOGY 348 , 2025 2025
Corrigendum to" Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism"[J. Ethnopharmacol. 326 (2024) 117935] ML Yellurkar, VS Prasanna, P Das, S Sarkar, R Matta, DK Dhaked, ... Journal of ethnopharmacology 348, 119766 , 2025 2025
Rudraksha attenuates right ventricular dysfunction in pulmonary hypertension induced Wistar rats P Das, B Kumar, ML Yellurkar, VS Prasanna, S Sarkar, AK Taraphdar, ... Pharmacological Research-Natural Products 6, 100180 , 2025 2025
MOST CITED SCHOLAR PUBLICATIONS
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma M Fujii, Y Shibazaki, K Wakamatsu, Y Honda, Y Kawauchi, K Suzuki, ... Medical molecular morphology 46 (3), 141-152 , 2013 2013 Citations: 444
Xanthine oxidase inhibitory activity of some Indian medical plants M Umamaheswari, K AsokKumar, A Somasundaram, T Sivashanmugam, ... Journal of ethnopharmacology 109 (3), 547-551 , 2007 2007 Citations: 307
Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the N rf2–keap1 pathway V Soetikno, FR Sari, AP Lakshmanan, S Arumugam, M Harima, K Suzuki, ... Molecular nutrition & food research 57 (9), 1649-1659 , 2013 2013 Citations: 256
Curcumin attenuates diabetic nephropathy by inhibiting PKC‐α and PKC‐β 1 activity in streptozotocin‐induced type I diabetic rats V Soetikno, K Watanabe, FR Sari, M Harima, RA Thandavarayan, ... Molecular nutrition & food research 55 (11), 1655-1665 , 2011 2011 Citations: 180
Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis V Karuppagounder, S Arumugam, RA Thandavarayan, R Sreedhar, ... Drug discovery today 21 (4), 632-639 , 2016 2016 Citations: 164
Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation R Afrin, S Arumugam, A Rahman, MII Wahed, V Karuppagounder, ... International immunopharmacology 44, 174-182 , 2017 2017 Citations: 163
Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling RA Thandavarayan, VV Giridharan, S Arumugam, K Suzuki, KM Ko, ... PloS one 10 (3), e0119214 , 2015 2015 Citations: 157
Modulation of HMGB1 translocation and RAGE/NF κ B cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... Experimental dermatology 24 (6), 418-423 , 2015 2015 Citations: 124
Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... International Immunopharmacology 23 (2), 617-623 , 2014 2014 Citations: 101
Schisandrin B ameliorates ICV-infused amyloid β induced oxidative stress and neuronal dysfunction through inhibiting RAGE/NF-κB/MAPK and up-regulating HSP/Beclin expression VV Giridharan, RA Thandavarayan, S Arumugam, M Mizuno, H Nawa, ... PLoS One 10 (11), e0142483 , 2015 2015 Citations: 98
Keratinocytes: an enigmatic factor in atopic dermatitis P Das, P Mounika, ML Yellurkar, VS Prasanna, S Sarkar, R Velayutham, ... Cells 11 (10), 1683 , 2022 2022 Citations: 95
Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats R Afrin, S Arumugam, V Soetikno, RA Thandavarayan, V Pitchaimani, ... Free radical research 49 (3), 279-289 , 2015 2015 Citations: 94
Tannic acid modulates NFκB signaling pathway and skin inflammation in NC/Nga mice through PPARγ expression V Karuppagounder, S Arumugam, RA Thandavarayan, V Pitchaimani, ... Cytokine 76 (2), 206-213 , 2015 2015 Citations: 92
Modulation of macrophage polarization and HMGB1-TLR2/TLR4 cascade plays a crucial role for cardiac remodeling in senescence-accelerated prone mice V Karuppagounder, VV Giridharan, S Arumugam, R Sreedhar, ... PloS one 11 (4), e0152922 , 2016 2016 Citations: 90
Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease R Sreedhar, S Arumugam, RA Thandavarayan, V Karuppagounder, ... Drug discovery today 21 (5), 843-849 , 2016 2016 Citations: 85
Depletion of 14-3-3 Protein Exacerbates Cardiac Oxidative Stress, Inflammation and Remodeling Process via Modulation of MAPK/NF-κB Signaling Pathways after Streptozotocin … RA Thandavarayan, VV Giridharan, FR Sari, S Arumugam, ... Cellular Physiology & Biochemistry (Karger AG) 28 (5) , 2011 2011 Citations: 83
Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK … S Arumugam, RA Thandavarayan, W Arozal, FR Sari, VV Giridharan, ... Free radical research 46 (2), 154-163 , 2012 2012 Citations: 81
Molecular understanding of curcumin in diabetic nephropathy V Soetikno, K Suzuki, PT Veeraveedu, S Arumugam, AP Lakshmanan, ... Drug discovery today 18 (15-16), 756-763 , 2013 2013 Citations: 69
Diabetic nephropathy: A twisted thread to unravel N Dagar, P Das, P Bisht, AK Taraphdar, R Velayutham, S Arumugam Life sciences 278, 119635 , 2021 2021 Citations: 64
The senescence accelerated mouse prone 8 (SAMP8): a novel murine model for cardiac aging V Karuppagounder, S Arumugam, SS Babu, SS Palaniyandi, K Watanabe, ... Ageing research reviews 35, 291-296 , 2017 2017 Citations: 64